TABLE 2.

Baseline characteristics of patients COVID-19 with new onset of ICH during infection.

Characteristic	Patient 1	Patient 2	Patient 3
Age (years)	56	64	60
Sex	Male	Male	Male
Smoking history	Yes	Yes	No
Blood pressure (mm Hg) (at the time of ICH detection)	160/80	210/90	165/89
Blood glucose (4.0–5.4 mmol/L)	6.0	11.0	16.8
Red blood cells count (4.5–5.7 × 1012/L)	3.8	3.0	2.8
Hemoglobin (115–160 g/L)	96	68	75
Erythrocyte Sedimentation Rate (ESR) (<20 mm/h)	18	27	21
White blood cells count (4.0–11.0 × 109/L)	14.8	15.0	15.2
Neutrophils (1.8–7.5 × 109/L)	12.5	12.3	14.8
Lymphocytes (1.5–4.0 × 109/L)	1.8	1.6	3.8
Eosinophils (0.0–0.4 × 109/L)	0.0	0.0	0.1
Monocytes (0.2–0.8 × 109/L)	1.2	0.6	0.5
Basophils (0.0–0.15 × 109/L)	0.0	0.1	0.0
Platelet count (150–450 × 109/L)	220	334	480
Creatinine (45–120 mmol/L)	66	138	130
Bilirubin, total (3–20 umol/L)	18	12	37
Total cholesterol (<5.2 mmol/L)	4.8	3.5	8.2
High-density lipoprotein (HDL) (>1 mmol/L)	1.3	1.1	1.8
Low-density lipoprotein (LDL) (<3.4 mmol/L)	2.8	3.5	5.17
D-Dimer (<500 ng/mL)	1820	2580	4000
Fibrinogen (2.0 to 4.0 g/L)	2.8	3.6	6.5
Activated partial- thromboplastin time (aPTT) (20–35 s)	22	25	21
International Normalized Ratio (INR) (0.85–1,15 ratio)	1.0	1.1	1.1
C-reactive protein (<5 mg/L)	88	120	189
Type of patients with COVID-19 (severe/non-severe)	Severe	Severe	Severe
Risk factors	Hypertension	Type 2 diabetes, hypertension	Hypertension, type 1 diabetes, high cholesterol,
The time between the onset of COVID-19 infection and onset of ICH (days)	21	10	12
Location of hematoma	Parietal-occipital region on the left with a breakthrough of blood into the ventricular system	In the projection of the basal ganglia on the right	In the projection of the basal ganglia on the right with a breakthrough into the ventricular system and a median dislocation to the left
Modified Rankin Scale (mRS, 0–6) (discharge)	4	2	5